What does CUSIP 45826J105 represent in this 13F holders report?

CUSIP 45826J105 is the security identifier for NTLA - Intellia Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held NTLA - Intellia Therapeutics, Inc. - Common Stock in Q1 2016?

1 institutional investor reported NTLA - Intellia Therapeutics, Inc. - Common Stock for Q1 2016. Use the holders table for investor-level position and value details.

Intellia Therapeutics, Inc. - Common Stock (NTLA)

CUSIP: 45826J105

Q1 2016 13F Holders as of 31 Mar 2016

Type / Class: Equity / Common Stock
Shares outstanding: 116,932,531
Total 13F shares: 215
Share change: 0
Total reported value: $4,000
Price per share: $18.60
Number of holders: 1

Quarterly Holders Quick Answers

What is CUSIP 45826J105?
CUSIP 45826J105 identifies NTLA - Intellia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q2 2016
Previous quarter: Q1 2010

Recent filing periods for CUSIP 45826J105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of NTLA - Intellia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Intellia Therapeutics, Inc. - Common Stock (NTLA) as of Q1 2016

As of 31 Mar 2016, Intellia Therapeutics, Inc. - Common Stock (NTLA) was held by 1 institutional shareholder that filed Form 13F with the SEC. Together, they reported ownership of 215 shares. The largest 1 holders included IFP Advisors, Inc. This page lists 1 institutional shareholders reporting positions in this security for the Q1 2016 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q1 2016 vs Q1 2010 Across Filers

Q1 2010 holders

Q1 2016 holders

Holder diff

Investor	Q1 2010 Shares	Q1 2016 Shares	Share Diff	Share Chg %	Q1 2010 Value $	Q1 2016 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.